People infected with HIV must take antiretroviral drugs for life. But engineered antibodies appeared to suppress the virus ...

UCSF researchers have made strides toward an HIV cure, showing experimental immunotherapy can help control the virus without ...

A three-drug cocktail used by many HIV-infected people proved clearly superior to other combinations at treating new patients in the biggest head-to-head comparison of AIDS medications to date. The ...

A new study from UC San Francisco shows it may be possible to control HIV without long-term antiviral treatment—an advance ...

Doctors treating a baby born with HIV have given the infant a clean bill of health after dosing the tot with a controversial cocktail of drugs. The unnamed tot - whose mum was not taking her HIV ...

The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported Wednesday. In clinical trials, the drug nearly eliminated HIV’s spread among ...

Scientists tested a multi-step immune-based therapy designed to retrain the body to control HIV without continuous antiviral treatment.

In recent years, the story around HIV has shifted dramatically. What was once viewed as a life sentence is now increasingly seen as a manageable condition. Medication is responsible for much of that ...

The US Food and Drug Administration (FDA) has approved 2 new HIV-1 cocktail drugs from Gilead Sciences, one an integrase inhibitor called elvitegravir (Vitekta) and the other a protease-inhibitor ...

(Reuters) - Gilead Sciences Inc said the U.S. Food and Drug Administration had approved its HIV drug cocktail, Genvoya, to treat patients aged 12 and above. Genvoya, a combination tablet approved as a ...